Buckingham Capital Management, Inc. Astrazeneca PLC Transaction History
Buckingham Capital Management, Inc.
- $844 Million
- Q4 2024
A detailed history of Buckingham Capital Management, Inc. transactions in Astrazeneca PLC stock. As of the latest transaction made, Buckingham Capital Management, Inc. holds 197,505 shares of AZN stock, worth $14.9 Million. This represents 1.53% of its overall portfolio holdings.
Number of Shares
197,505
Previous 195,004
1.28%
Holding current value
$14.9 Million
Previous $15.2 Million
14.83%
% of portfolio
1.53%
Previous 1.76%
Shares
31 transactions
Others Institutions Holding AZN
# of Institutions
1,358Shares Held
512MCall Options Held
6.08MPut Options Held
4.44M-
Price T Rowe Associates Inc Baltimore, MD60.4MShares$4.55 Billion0.46% of portfolio
-
Primecap Management CO Pasadena, CA41MShares$3.09 Billion2.12% of portfolio
-
Capital International Investors Los Angeles, CA37.5MShares$2.83 Billion0.48% of portfolio
-
Wellington Management Group LLP Boston, MA37MShares$2.79 Billion0.46% of portfolio
-
Bank Of America Corp Charlotte, NC24MShares$1.81 Billion0.13% of portfolio
About ASTRAZENECA PLC
- Ticker AZN
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 3,099,020,032
- Market Cap $234B
- Description
- AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...